CA Stock MarketDetailed Quotes
LILY Callitas Health Inc
- 0.000
- 0.0000.00%
15min DelayTrading Nov 7 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio45.27MShares0.00052wk Low-0.02EPS TTM0Float Cap0.000Historical High0.00P/E (Static)45.27MShs Float0.000Historical Low-0.04EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Callitas Health Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | (FY)Dec 31, 2018 | (Q4)Dec 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 20.07%-127.01K | 120.29%83.34K | 95.34%-21.01K | -727.10%-1.15M | -150.57%-132.44K | -8,405.85%-158.89K | -240.63%-410.69K | -1,210.75%-450.87K | 106.80%183.85K | -90.98%261.91K |
| Net income from continuing operations | 37.55%-166.85K | 66.24%-134.84K | 81.54%-142.99K | 68.96%-1.7M | 93.90%-257.86K | 27.49%-267.18K | 37.68%-399.39K | -230.42%-774.47K | 36.19%-5.47M | -28.72%-4.23M |
| Operating gains losses | -121.57%-33.35K | -711.22%-51.89K | -142.43%-43.58K | 88.04%-29.91K | ---126.07K | ---15.05K | --8.49K | --102.72K | 33.12%-250.06K | ---- |
| Depreciation and amortization | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 5.42%466.45K | -73.82%115.37K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -1.20%4.32M | -1.20%4.32M |
| Remuneration paid in stock | --0 | --0 | --0 | 78.04%229.44K | -91.79%10.58K | --10.58K | --10.58K | --197.7K | -70.04%128.87K | -70.04%128.87K |
| Other non cashItems | 89.84%74.89K | 24.15%73.73K | 25.89%67.31K | 10,964.13%468.9K | --316.59K | --39.45K | --59.39K | --53.47K | -100.60%-4.32K | ---- |
| Change In working capital | -102.32%-1.7K | 318.75%196.34K | 424.37%98.24K | -112.25%-122.42K | -140.96%-75.68K | -71.33%73.31K | -122.44%-89.76K | -119.06%-30.29K | 17,346.45%999.43K | -40.54%184.8K |
| -Change in receivables | --0 | --0 | --108.65K | -845.57%-163.65K | -4,985.93%-162.12K | ---1.53K | --0 | --0 | 2,414.20%21.95K | 173.42%3.32K |
| -Change in inventory | 38.79%-22.73K | -5.87%-75.41K | 97.10%-1.36K | -105.24%-2.53K | 334.00%152.64K | -612.73%-37.13K | -640.67%-71.22K | -1,019.21%-46.81K | 142.38%48.22K | 160.10%35.17K |
| -Change in prepaid assets | --0 | 1,118.09%15.25K | --31.65K | -211.03%-36.72K | -351.84%-36.72K | -89.17%1.5K | -132.10%-1.5K | --0 | 60.90%33.08K | -61.69%14.58K |
| -Change in payables and accrued expense | -49.84%45.42K | 579.09%247.22K | -11.33%-34.8K | -86.12%108.54K | 472.71%100.87K | -63.36%90.54K | -113.51%-51.6K | -123.10%-31.26K | 803.32%782.07K | -94.75%17.61K |
| -Change in other working capital | -222.35%-24.39K | -73.16%9.28K | -112.33%-5.89K | -124.60%-28.07K | ---130.35K | --19.93K | --34.57K | --47.78K | --114.12K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 20.07%-127.01K | 120.29%83.34K | 95.34%-21.01K | -727.10%-1.15M | -150.57%-132.44K | -8,405.85%-158.89K | -240.63%-410.69K | -1,210.75%-450.87K | 106.80%183.85K | -90.98%261.91K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -72.07%66K | 0 | -95.08%34.19K | 485.13%1.17M | 122.92%84.61K | 236.32K | 31.06%157.63K | 1,343.91%695.26K | -112.72%-304.79K | 94.94%-369.17K |
| Net issuance payments of debt | -73.28%66K | --0 | -87.22%34.19K | 727.39%649.5K | --135K | --247K | --0 | --267.5K | --78.5K | --0 |
| Net common stock issuance | --0 | --0 | --0 | 1,055.10%906.75K | --0 | --0 | --289.23K | --617.53K | -97.18%78.5K | 98.93%-72K |
| Net other financing activities | ---- | ---- | ---- | 17.18%-382.43K | 83.04%-50.39K | ---10.68K | -21.03%-131.6K | -239.52%-189.77K | -17.82%-461.79K | 60.28%-297.17K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -72.07%66K | --0 | -95.08%34.19K | 485.13%1.17M | 122.92%84.61K | --236.32K | 31.06%157.63K | 1,343.91%695.26K | -112.72%-304.79K | 94.94%-369.17K |
| Net cash flow | ||||||||||
| Beginning cash position | 188.57%77.03K | -73.76%63.57K | 3,360.46%15.05K | -97.30%435 | 1,777.37%45.88K | 4,926.93%26.69K | 29,263.76%242.25K | -97.30%435 | -97.75%16.13K | -98.61%2.44K |
| Current changes in cash | -178.79%-61.01K | 132.93%83.34K | -94.61%13.18K | 117.31%20.93K | 55.41%-47.83K | 3,947.57%77.43K | -85,974.83%-253.06K | 1,697.18%244.39K | 82.70%-120.94K | 32.65%-107.26K |
| Effect of exchange rate changes | 109.55%5.56K | -286.33%-69.88K | 1,475.40%35.33K | -106.00%-6.31K | --17K | ---58.24K | --37.5K | ---2.57K | --105.25K | ---- |
| End cash Position | -52.96%21.58K | 188.57%77.03K | -73.76%63.57K | 3,360.46%15.05K | 3,360.46%15.05K | 1,777.37%45.88K | 4,926.93%26.69K | 29,263.76%242.25K | -97.30%435 | -97.30%435 |
| Free cash from | 20.07%-127.01K | 120.29%83.34K | 95.34%-21.01K | -727.10%-1.15M | -150.57%-132.44K | -8,405.85%-158.89K | -240.63%-410.69K | -1,210.75%-450.87K | 105.94%183.85K | -96.33%261.91K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data